Inhibitor development and clinical characteristics in children with severe hemophilia A in the ATHN 8 US Cohort Study
Author(s):
Courtney D. Thornburg, H. Marijke van den Berg, Martin Chandler, Lynn Malec, Matthew Manuel, Carrie O’Neill, Michael Recht, Elizabeth Taggart, Shannon L. Carpenter for the American Thrombosis and Hemostasis Network (ATHN) 8 investigators study group
Real-World Use of Recombinant Factor IX Fusion Protein in Previously Untreated Patients with Congenital Hemophilia B from the ATHN 8 Study
Author(s):
Courtney Thornburg, Martin Chandler, Lynn Malec, Matthew Manuel, Carrie O’Neill, Michael Recht, Elizabeth Taggart, Hongseok Kim, Vindhi Desai, Hiren Shah, Shannon Carpenter
Publication:
Thrombosis & Hemostasis Summit of North America (THSNA) 2024
U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Inhibitor Development and Treatment Characteristics
Author(s):
Shannon L Carpenter, Martin Chandler, Michael F Guerrera, Lynn Malec, Matthew Manuel, Michael Recht, Ulrike Reiss, Robert F Sidonio Jr, Cristina Tarango, Marijke Van den Berg, Michael Wang, Courtney D Thornburg
U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Study): Association Between Family History and Age of Diagnosis
Author(s):
Courtney Thornburg, Kenneth Friedman, Michael Guerrera, Chunla He, Lynn M Malec, Mindy L Simpson, Michael D Tarantino, Marijke Van Den Berg, Crystal Watson, Shannon L Carpenter
U.S. Cohort Study of Previously Untreated Patients with Congenital Hemophilia (ATHN 8: PUPs Matter Study): Interim Analysis of the 2010-2019 Birth Cohort
Author(s):
Shannon Carpenter, Chunla He, Lynn Malec, Amanda Payne, Marijke van den Berg, Crystal Watson, Courtney Thornburg
Publication:
International Society on Thrombosis and Haemostasis (ISTH) 2020 Virtual Congress